Skip to content

FDA names former pharmaceutical company executive to oversee US drug program

As the agency’s top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Health Secretary Robert F. Kennedy Jr.

FILE – The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana, File)
FILE – The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana, File)
Author
UPDATED:

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

Originally Published:

RevContent Feed

Page was generated in 2.3052501678467